01 1Atidarsagen Autotemcel
02 3BUROSUMAB
03 1BUROSUMAB-TWZA
04 21Burosumab
05 1CD34+ Cell-Enriched Population Transduced with Lentiviral Vector Encoding Human Arylsulfatase A Gene, Autologous Human
06 2Droperidol
07 1Evocalcet
08 14Fentanyl
09 1Fentanyl Citrate
10 2Granisetron
11 2ISTRADEFYLLINE
12 1Iron
13 1MOGAMULIZUMAB
14 1MOGAMULIZUMAB-KPKC
15 4Mitomycin
16 2Mogamulizumab
17 1Mogamulizumabum
18 2Nitroglycerin
19 1TOREMIFENE CITRATE
20 2Testosterone
21 6naloxegol
01 5KYOWA KIRIN
02 6KYOWA KIRIN AUSTRALIA PTY LTD
03 9KYOWA KIRIN LIMITED
04 4KYOWA KIRIN, INC.
05 1Kyowa Kirin
06 7Kyowa Kirin Holdings B.V.
07 7Kyowa Kirin Holdings Bv
08 21Kyowa Kirin Limited
09 4Kyowa Kirin S?rl
10 2Orchard Therapeutics (Netherlands) Bv
11 2PROSTRAKAN LTD
12 1ProStrakan Ltd
13 1Prostrakan Ltd
01 6Antic-calc Tablet, Film Coated
02 1Concentrate For Infusion Solution
03 2Concentrate For Solution For Infusion
04 1Dispersion For Perfusion
05 1Fentanyl 100Mcg 10 Units Sublingual Use
06 1Fentanyl 200Mcg 10 Units Sublingual Use
07 1Fentanyl 300Mcg 10 Units Sublingual Use
08 1Fentanyl 400Mcg 10 Units Sublingual Use
09 1Fentanyl 600Mcg 10 Units Sublingual Use
10 1Fentanyl 800Mcg 10 Units Sublingual Use
11 1Gel
12 1Granisetrone 3,1Mg 1 Unit Transdermal Use
13 2INJECTABLE;INJECTION
14 1Infusion Solution
15 7Injectable Solution
16 3Injectable Solution In Pre-Filled Syringe
17 1Injection fluid, resolution
18 1Mitomycin 10Mg 1 Unit Parenteral Use
19 1Mitomycin 40Mg 1 Unit Parenteral Use
20 1Oral Solution
21 1Rectal Salve
22 4SOLUTION
23 8Solution For Injection
24 1Sublingual Tablet
25 8Sublingual tablet
26 3TABLET;ORAL
27 1Tablet
28 1Transdermal patches
29 8Blank
01 11 transdermal patch 3.1 mg/24 die
02 11 vial EV 10 mg
03 11 vial EV 40 mg
04 110 cpr subling 100 mcg
05 110 cpr subling 200 mcg
06 110 cpr subling 300 mcg
07 110 cpr subling 400 mcg
08 110 cpr subling 600 mcg
09 110 cpr subling 800 mcg
10 2100 mcg
11 210MG
12 210MG/ML
13 210mg
14 110mg/ml
15 212.5 mg
16 11mg/ml
17 12%
18 12-10millioncells/ml
19 12.5 mg/ml
20 12.5mg/ml
21 2200 mcg
22 320MG
23 120MG/5ML
24 120MG/ML
25 220mg
26 120mg/ml
27 425 mg
28 13.1 mg/24 hours
29 1300 mcg
30 230MG
31 130MG/ML
32 230mg
33 130mg/ml
34 14 mg/g
35 1400 mcg
36 140MG
37 24MG
38 14MG/ML
39 14mg/5ml
40 14mg/ml
41 150mcg
42 15ML
43 1600 mcg
44 1800 mcg
45 1EQ 60MG BASE
46 1Gel 60 G 2%
47 1Ung Rett 30 G 4 Mg/G
48 8Blank
01 6Australia
02 4Canada
03 11Italy
04 1Japan
05 1Malta
06 18Norway
07 8Spain
08 12Sweden
09 4Switzerland
10 5USA
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Dispersion For Perfusion
Brand Name : Libmeldy 2-
Dosage Strength :
Packaging :
Approval Date : 2021-10-19
Application Number : 1201493001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Injectable Solution
Brand Name : Crysvita
Dosage Strength : 10mg
Packaging :
Approval Date : 19/02/2018
Application Number : 20161206000011
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 10mg
Packaging :
Approval Date : 30/11/2023
Application Number : 20230530000063
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Injectable Solution
Brand Name : Crysvita
Dosage Strength : 20mg
Packaging :
Approval Date : 19/02/2018
Application Number : 20161206000028
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 20mg
Packaging :
Approval Date : 30/11/2023
Application Number : 20230530000070
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Injectable Solution
Brand Name : Crysvita
Dosage Strength : 30mg
Packaging :
Approval Date : 19/02/2018
Application Number : 20161206000035
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 30mg
Packaging :
Approval Date : 30/11/2023
Application Number : 20230530000087
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 10mg/ml
Packaging :
Approval Date : 20/01/2020
Application Number : 66801
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 20/01/2020
Application Number : 66801
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Solution For Injection
Brand Name : Crysvita
Dosage Strength : 30mg/ml
Packaging :
Approval Date : 20/01/2020
Application Number : 66801
Regulatory Info : Allowed
Registration Country : Switzerland
Kyowa Kirin is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find a price of 7-Hydroxystaurosporine bulk offered by Kyowa Kirin
Find a price of Istradefylline bulk offered by Kyowa Kirin
Find a price of Olopatadine Hydrochloride bulk offered by Kyowa Kirin
Find a price of RGI-2001 bulk offered by Kyowa Kirin
Find a price of Spicamycin Analog bulk offered by Kyowa Kirin
Find a price of KW-6356 DRUG SUBSTANCE bulk offered by Kyowa Kirin
Find a price of ASKP1240 MONOCLONAL ANTIBODY DRUG SUBSTANCE AND DRUG PRODUCT bulk offered by Kyowa Kirin
Contact Us!
